$VERU insiders have traded $VERU stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

Veru Inc. (VERU) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

At its 2026 Annual Meeting of Shareholders held on March 12, 2026, Veru Inc. won investor approval to significantly expand its 2018 Equity Incentive Plan, more than doubling the pool of common shares ...

MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for ...

On August 8, Veru reveals figures for the most recent quarter. Analysts on Wall Street expect Veru will release losses per share of $0.058. Track Veru stock price in real-time on Markets Insider here.

Veru (NASDAQ:VERU) is set to give its latest quarterly earnings report on Wednesday, 2026-02-11. Here's what investors need to know before the announcement. Analysts estimate that Veru will report an ...

MIAMI, FL, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (VERU) on a split-adjusted basis at the market open on August 11, 2025 with the new CUSIP number 92536C202. At the effective time, all ...

Veru Inc. (NASDAQ:VERU) stock is plummeting on Monday after the company released topline results from the Phase 2b QUALITY clinical study of enobosarm for weight reduction. The study evaluates the ...

Veru (NASDAQ:VERU) just reported results for the first quarter of 2024. Veru reported earnings per share of -8 cents. This was above the analyst estimate for EPS of -13 cents. The company reported ...